In May 2024, French pharmaceutical giant Sanofi announced a three-way collaboration with Formation Bio and OpenAI to develop AI software for drug research. William Tsai, Sanofi's Head of Public ...

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi ...

Sanofi, Formation Bio and OpenAI have jointly designed an AI-powered tool that will be rolled out in the former's phase 3 multiple sclerosis trials. There’s a new Muse in town.

PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and ...

OpenAI develops artificial intelligence models and is known for its generative AI technologies, including ChatGPT. Duke and OpenAI are launching what’s believed to be the first AI metascience research ...

Mattel is partnering with OpenAI to develop AI-powered toys and experiences around its portfolio of brands. The maker of Barbie dolls and Hot Wheels cars said Thursday that the agreement will ...

Palantir, the company named for the dangerous seeing-stones that tended to mislead their users, has announced a partnership ...

Axios is expanding its local newsletter presence from 30 to 34 cities. The catch? OpenAI is funding it. In its continued ...

The University of Michigan has partnered with OpenAI, an artificial intelligence development company, to establish new research funding and AI resources that will help the University to advance its ...

PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and ...